Abstract

Purpose This study aims to examine the prevalence rate of ocular manifestations and the positive rate for the real-time reverse transcriptase-polymerase chain reaction (RT-PCR) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in conjunctival/tear swabs among adult patients with coronavirus disease 2019 (COVID-19). Methods PubMed and EMBASE were reviewed between December 1, 2019, and January 31, 2021, and only peer-reviewed clinical studies in our pooled analyses were included. Details regarding the patient numbers, demographics, ocular manifestations, positivity of ocular surface RT-PCR, and severity of pneumonia were recorded from each study. Primary outcomes were the occurrence of ocular manifestations and virus detection on the ocular surface. Meanwhile, secondary outcomes included frequencies of various ocular symptoms/signs (s/s), the proportion of patients with ocular manifestation as the initial symptom, and the relationship between the severity of pneumonia and the presentation of ocular manifestations. Results In total, 35 studies with 4,432 adult COVID-19 patients were included in this analysis. The overall prevalence rate of ocular manifestations was found to be 11.3%, and the positive rate of SARS-CoV-2 in the ocular surface was 7.4%. The four most common ocular s/s were follicular conjunctivitis, redness, watering, and discharge. A proportion of 3.3% presented with ocular s/s preceding other findings. Besides, patients with higher severity of pneumonia were more likely to have ocular manifestations (odds ratio = 2.25; 95% confidence interval (CI): 1.45–3.50). Conclusion As per our findings, it was determined that ocular transmission of SARS-CoV-2 might be possible, highlighting the importance of eye protective equipment among healthcare personnel.

Highlights

  • Coronavirus disease 2019 (COVID-19) is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARSCoV-2)

  • Our study found an overall proportion of ocular manifestations among COVID-19 patients to be 11.3%, which was compatible with previous meta-analyses performed by Aggarwal et al [5] and Inomata et al [6]

  • Accepted protocols of data collection and ocular PCR should be applied in upcoming studies. This meta-analysis has demonstrated the possibility of ocular manifestations and virus detection in the ocular surface of COVID-19 patients

Read more

Summary

Introduction

Coronavirus disease 2019 (COVID-19) is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). It was recognized by the World Health Organization (WHO) as a pandemic in March 2020. SARS-CoV-2 has been determined to bind to the angiotensin-converting enzyme 2 (ACE2) receptor, which is mostly located in the lung, heart, gastrointestinal tract, and kidney [1, 2]. The most common symptoms/signs (s/s) are dyspnea, fever, diarrhea, and heart/renal failure. The conjunctiva has a lower concentration of ACE2 receptors, is exposed to the environment, and is contacted with the respiratory droplets or hands capable of carrying viruses

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call